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new, cost-effective antimalarials as these compounds are important intervention 
tools. 
Malaria is associated with poverty and in a continent with already fragile 
economies and poor health services, the disease is an impediment to development 
and in highly endemic countries, the disease causes a 1.3% loss of economic 
growth annually (WHO Malaria Fact Sheet N° 19,2007). 
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Figure 1.2. Parasite life cycle (from Miller et 01, 2002). 
Disease is initiated by the asexual replication of parasites in the red blood cells. 
Fever and anaemia are key features of disease, resulting from the rupture of 
erythrocytic schizonts. This is generally accompanied by headache, vomiting and 
muscle pains. In falciparum malaria, convulsions and coma are common 
complications possibly caused by the adhesion of red blood cells to cerebral 
capillaries. Sequestration of infected erythrocytes was associated with 
upregulation of intercellular adhesion molecule 1 (ICAM-I) which is mediated by 
the nuclear transcription factor NF-KB (Tripathi et ai, 2006). Interestingly, Liu et 
al (2007) recently found that a group of flavonoids known as chalcones (see 
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1.3. Chemical structures of artemisinin and its derivatives. 1, 




































Figure 1.4. The PRT protein family common fold. The structure represents HGPRT from 
Trypanosoma crozi in complex with hypoxanthine (purine base), PRPP and Mg2+. The dark blue 
region represents the conserved Mg'PRPP binding loops, the core domain is represented by green 
(l helices and red ~ sheets, and the light blue structure is the hood domain. The black sphere is 
MgZT , carbon atoms are orange, oxygen atoms are red, nitrogen atoms are blue, and phosphorus is 
coloured green. The figure was taken directly from Sinha and Smith (200 I). 
The conserved PRPP-binding site consists of a PP j loop, a flexible loop and a 
PRPP loop. The amino acid residues of these loops are not conserved across 











The high conservation within a class is illustrated in Figure 1.5, where the 
sequences of five HGPRTs are compared. The polypeptides range in size from 
~21 kDa to -26 kDa (Free et ai, 1990; Vasanthakumar et ai, 1994, Shahabuddin 
and Scaife, 1990; Vasanthakumar et ai, 1994; Allen and Ullman, 1994; Chin and 
Wang, 1994). 
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Figure 1.5. Amino acid sequence alignment of human, Toxoplasma gondii, Plasmodium 
jalciparum, Trypanosoma cruz; and Tritrichomollasjoetus HGPRTs. Figure taken, with 
permission, from Heroux et ai, 1999a. Gold stars below the sequence indicate active site residues. 
Conserved residues are shaded green and those that are conservatively substituted are yellow. 
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The first crystal structure of an HGPRT was that of the human enzyme with bound 
GMP (Eads et ai, 1994), followed by the structure of the free enzyme detailing the 
confonnational changes necessary for catalysis (Keough et ai, 2005). The crystal 
structure of a chimera of human and P. Jalciparum was recently published 
(Gayathri et ai, 2008) and it is hoped that the structure would provide useful 
infonnation for designing selective inhibitors against the malarial enzyme. 
Several crystal structures ofHGPRTs from other organisms have since been 
published. T. gondii (Schumacher et ai, 1996) and T. cruzi (Focia et ai, 1998) 
structures were published in short succession. HGPRT from T. gondii was further 
crystallised with GMP and IMP, respectively (Heroux et ai, 1999a) and later with 
XMP, PPj and two Mg2+ ions (Heroux et ai, 1999b). Based on these structures, 
Heroux et al (1999b) proposed the first detailed structure-based description of 
HGPRT catalysis shown in figure 1.7 (A-F)I. 
PRPP is entering the active site 
of the apoenzyme. Here, loops 
II, III, III' and the purine-binding 
site (1Ie148, Trp1 99) are open. 
Loop IV closes once PRPP is 
fully bound. 
A 










wnThe bisubstrate complex. 
Loop III is ordered by the 
binding of the 5'-phosphate 
group (of PRPP) and the 
purine-binding clamp is closed 
around the base. Loop III' is 
now able to approach the active 




The PRPP complex. PRPP and 
Mg2+ are bound and the hood 
closes onto the core domain. The 
pyrophosphate group is held in 
position by the two Mg2+ ions, 
prepared for phosphoribosyl 
transfer. Guanine is shown 
entering the active site , following 
which the purine-binding clamp 
will close. 
RI82 
I ... Loop Ill' 
. } 1 
The biproduct complex. Loop II 
is closed, placing Tyr118 in 
position to hydrogen-bond to the 
5' -phosphate group. The opening 
of loops I and IV will now allow 










The nucleotide complex. Here, 
PPj is shown leaving the active 
site and loop II has reopened. 
Loop III' and the hood will now 
open as the departure of PPj 
destabilises the interactions 
linking the core and hood in the 
lower active site. This event 
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The apoenzyme. The sequential 
opening of the hood domain, loop 
III', and finally loop III, is followed 
by the release of GMP in the rate-
limiting step of the catalysis . 
HGPRT now returns to the 
apoenzyme state . 
Figure 1.7. Structure-based description of HGPRT catalysis. Green ribbons represent the 
enzyme. The hood and core domains are, as indicated in A, at the upper left and lower right 
comers, respectively. The active site loops are coloured as follows: I, lavender; II, pink; III, gold; 
III', grey and IV, orange. 
The human (Shi et ai, I 999a) and malarial (Shi et aI, 1999b) enzymes were 
crystallised with transition state inhibitors (immucillinGP and immucillinHP, 
respectively, see figure 1.8). The equilibrium inhibition constants for these 
transition state analogues have been shown to be lower than for the enzyme 











compounds with greater specificity for protozoal HGPRTs over the human fonn 
(Li et ai, 1999). Chemical structures of these inhibitors are shown in figure 1.8. 
OPO, OPO, 
Figure 1.8. Transition state inhibitors of humHGPRT and PjHGPRT, immucillinGP (A) and 
immucillinHP (B) (Shi et aI, 1999a; Shi et aI, 1999b) 
1.4.2 Plasmodium Jalciparum HGXPRT2 
PjHGXPRT was initially purified from P.falciparum grown in culture and was 
shown to be highly unstable and have very low activity (Queen et ai, 1988) 
compared to the human homologue. Recombinant protein expressed in 
E. coli (Shahabuddin and Scaife, 1990; Keough et ai, 1999; Phehane, 2002; 
Mbewe et ai, 2007) is inactive as isolated in a highly purified form but may be 
activated by prolonged incubation with partial substrates, i.e. hypoxanthine + 
PRPP (no added Mg2+) or MgPRPP, so that an active form of the enzyme is 
stabilised without inducing turnover (Keough et ai, 1999; Phehane, 2002). 
However, the enzyme rapidly inactives during enzyme assay under standard 
conditions (Phehane, 2002). 
The enzyme consists of231 amino acids and has a molecular mass of26 232 Da. 
Ultracentrifugation studies showed that PjHGXPRT is tetrameric at low salt 
concentrations and dimeric at high salt concentrations (Keough et ai, 1999). 
Although the PjHGXPRT is 44% homologous to the human enzyme (Shi et ai, 
1999b), it has broader substrate specificity, i.e. the protozoal enzyme is able to use 
hypoxanthine (Webster et ai, 1984; Asahi et ai, 1996), guanine and xanthine as 
2 HGXPRT differentiates the P.falciparum phosphoribosyltransferase from the human homologue 











substrates whereas the human homologue is unable to utilise the latter (Queen et 
aI, 1988). 
Only one crystal structure of PjHGXPRT exists, that of the enzyme in complex 
with a transition-state analogue inhibitor, as mentioned above (Shi et aI, 1999a). 
The difficulty in obtaining crystals in the absence of such tight binding 
compounds may be attributed to the intrinsic instability of the enzyme and the fact 
that the isolated enzyme is inactive (Keough et ai, ] 999). The 2.0 A structure of 
PjHGXPRT with imrnucillinHP revealed a tetramer, with each subunit consisting 
of six a-helices and eleven ~-strands (see figure 1.9). Within each subunit 
(monomer) there is a core domain (residues 46 - 194) and a hood domain (residues 
1 - 45 and 193 - 231). 
Figure 1.9. Subunit of P. Jalciparum HGXPRT. The monomer is complexed with the transition 












ImmucillinHP, two Mg2+, and PPj were bound at each of the four active sites of 
the tetramer (see figure 1.10) with ~4' and ~S folded over the catalytic site. 
Although the human and malarial homologues differ in substrate specificity, the 
structures of the enzymes with bound immucillins show that amino acid residues 
in contact with the inhibitors are conserved and the active site complexes show 
marked similarity. 
Figure 1.10. ImmucillinHP (light blue), PP; (pink), and two Mg'+ (green spheres) bound at the 
active site of P.jaiciparum HGXPRT in a mimic of the closed transition state. Red spheres are 
water molecules. Key residues ligating the bound substrates/pseudosubstrates are indicated. 
1.5 FlavoDoids 
The number of flavonoids that have been isolated from plants exceeds 4000 and 
these compounds can be classified into six groups (see figure 1.11). A wide range 
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meant to destabilise the protein-ligand interaction but care needs to be taken that 
the protein of interest is not denatured (Voet and Voet, 1995). In some cases, the 
protein may also be eluted from the column by the addition of a solution 
containing a higher concentration of the ligand than that bound to the matrix of the 
column, such that the competitive effect displaces the protein from the resin. 
(Horton et ai, 2002). 
Dye-ligand affinity chromatography involves the use of synthetic dyes 
covalently attached to agarose as ligands for the purification of macromolecules. 
These dyes are composed of a chromophore (often laced with suI phonic acid 
groups) and a reactive group (which pennits covalent attachment to the agarose). 
The chromophore is designed to mimic enzyme substrates. For example, Reactive 
Red-120 (figure 2.2) contains a chromophore that resembles nucleotides and 
therefore often binds nucleotide-binding proteins. The dye-agarose resins are 
especially useful as they are commercially available and inexpensive, and are 
more attractive than other ligands such as antibodies and nucleotides which are 
costly and tend to be difficult to immobilise. 
Figure 2.2. Chemical structure of Reactive Red-l20. The molecule reacts with the agarose via 
the chloro groups (green) in order to irnrnobilise the resin. The S of the negatively-charged 
sulphonate groups is shown in orange/yellow. 
Cell pellets obtained as described before were thawed on ice and then resuspended 
in 50 mM Tris-CI, pH 8.0, 25 mM NaCI, 2 mM EDT A, 1 mM PMSF and 1 mM 
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2.3. for the retention volume for a on filtration 
HPLC. The void volume is the volume of the mobile between the beads of the 
The coefficient reflects the extent to which a can the ~ • .,.,,,,,,., 
and the included volume is the volume of the mobile within the porous beads. The 
retention volume of a 
curve constructed 
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Figure 2.4. Chemical structure ofTNP-8NJ-ATP. The 32p atom in [y_
32p]TNP-8Nr ATP is 
indicated by the black arrow. [y)2p]TNP-8N3-ATP, a light-sensitive A TP analogue was used to 
covalently derivatise PjHGXPRT . 
In the present study, we explored the use of the radioactive photolabel 
[y}2p]TNP-8N3-A TP (figure 2.4) as a possible probe of the active site of 
PjHGXPRT. Even though the TNP nucleotide is different and larger compared to 
the enzyme substrates and products, the structures of the homologous apoenzyme 
from Toxoplasma gondii and human show that the active site is wide open - all 
the loops that fold over the bound substrates are well apart - and it is certainly 
conceivable that TNP-8N3-ATP, with the tail of the phosphate chain extending out 
of the site (see later). In a previous study (Murungi, 2007), the use of 
[y-32p]TNP-8N3-ITP was found to be reasonably effective as a photoprobe of 
PjHGXPRT (~.5 in the low micromolar range), however the synthesis of this 
probe starts with [y}2p]TNP-8N3-ATP and requires further chemical steps. It 
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Figure 2.6. Model ITC raw data for an exothermic reaction. The inset shows an ITe reaction 
cell (containing the protein - red blobs) and injection syringe (containing the ligand - green blobs) 
which stirs the contents of the cell to ensure homogeneity. The titration is effected by timed 
injections of a fixed volume of the ligand into the cell thereby producing characteristic "heats of 
injection" (main thermogram). The heat produced is initially maximal as the binding sites are 
largely empty, then as the sites available become less the amount of heat produced diminishes, 
until saturation, where the heat produced is the result of dilution of the protein only and these tail 
end values should be subtracted from the earlier data prior to analysis. The area under each peak is 
the heat associated with each timed injection needed to maintain the temperature between the 
reference and reaction cells. The figure was taken directly from Leavitt and Freire (200 I). 
All ITC experiments in the present study were carried out using a VP-ITC 
microcalorimeter (Microcal, Inc.) with a cell volume of200-300 )..il and a total 
volume delivered from the syringe of 35-40)..il. The experiments were conducted 
at 25°C, the cell stirred at 500 rpm, and the intervals between injections 180 s. 
Solutions were stirred and degassed prior to use (under vacuum) to avoid bubbles. 
It is important that the two solutions in the cell and syringe are matched in 
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CHAPTER 3: Results 
3.1 Transformation, Expression, Purification and Activation of his-tagged 
PjHGXPRT 
3.1.1 Transformation of E. coli with PjHGXPRT/pET15b 
The expression strain, E. coli BL21 (DE3)pLysS, was successfully transfonned 
with recombinant pET15b containing the insert encoding PjHGXPRT. Glycerol 
stocks of these cells were stored at -81°C. 
3.1.2 Expression and purification of PjHGXPRT from pET15b 
Initial experiments yielded low levels of the target protein and it was decided to 
prepare a fresh IPTG stock solution and to compare expression levels when using 
this and a solution that had been frozen at -20°C for approximately three months. 
However, induction with fresh 0.4 mM IPTG at 37°C produced no signjficant 
differences in expression levels (see figure 3.1). 
97.4 ----+ 
45 ----+ 
3 I ----+ -'" 
21.5 ----+ 
14.4 ----+ 
2 3 4 5 6 
- --
Figure 3.1 SDS-PAGE analysis of his-tagged PjHGXPRT expression at 37°C with froun and 
fresh IPTG stock solutions. Aliquots of I ml culture were taken before and after 3 h induction 
with 0.4 mM IPTG, solubilised, and 20 III subjected to SDS-PAGE with 14% acrylamide. 1, 
Molecular weight markers (kDa); 2, Before induction; 3 and 4, After induction with "old" IPTG 
stock solution (frozen for 3 months); 5 and 6, After induction with fresh IPTG. The right hand 











Nevertheless, despite low expression levels, it was decided to subject the 
preparation to Ni-chelate chromatography and the results are shown in figure 3.2. 
The supernatant (lanes 2 and 3) shows the poor expression. The pellet (lane 4) 
contains negligible amounts of the protein of interest indicating it is not in 
inclusion bodies. Passage through the Ni-chelate column decreased the amount of 
PjHGXPRT in the material flowing through (lane 5). Most of the PjHGXPRT 
was eluted in the first 2 ml of 1 M imidazole (lanes 7 and 8). The preparation is 





2 3 4 5 6 7 8 
Figure 3.2 Purification of his-tagged PjHGXPRT using nickel-affinity chromatography after 
induction with 0.4 mM IPTG at 37°C, 1, Molecular weight marker (kDa); 2, Supernatant before 
filtration; 3, Supernatant after filtration; 4, Crude pellet (resuspended to the same volume as the 
supernatant) after induction; 5, Flow-through; 6, 5 mM imidazole wash fraction (5 ml); 7, 2 ml 
1 M imidazole fraction; 8, further 2 ml 1 M imidazole. The right hand arrow indicates the position 
of PjHGXPRT (~26 kDa). Equal volume aliquots were placed in each well. 
Studier (2005) found that it is beneficial to induce expression at 25°C rather than 
37°C. Also, a recent study by Berwal et al (2008) on the expression oflactate 
dehydrogenase from P. Jalciparum showed that decreasing the temperature of 
induction was crucial for obtaining better yields of soluble protein when the 
enzyme was overexpressed in E. coli. Induction of PjHGXPRT expression at 25°C 
showed significantly increased yields (see supernatant, lanes 2 and 3, figure 3.3) 
and this led to a much purer preparation after Ni-chelate chromatography (lanes 7 
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Figure 3.3. Purification of his-tagged PjHGXPRT using nickel-affinity chromatography 
after induction with 0.4 mM IPTG at 25°c' 1, Molecular weight markers (kDa); 2, Supernatant 
before filtration; 3, Supernatant after filtration; 4, Crude pellet (resuspended to the same volume as 
the supernatant) after induction; 5, Flow-through; 6, 5 mM imidazole wash fraction (5 ml); 7 - 10, 
I M imidazole fractions (2 ml aliquots) . The arrow on the right indicates the position of 
PjHGXPRT (-26 kDa). Equal volume aliquots were placed in each well. 
We attempted to obtain better purification by increasing the concentrations of 
imidazole and NaCI in the solutions used to wash the nickel column before elution 
of the target protein and such an experiment, in which a 60 mM imidazole + 1 M 
NaCI wash was included, is shown in figure 3.4 [note that nonnally 500 mM NaCI 
was included in all buffers]. However, a significant amount of the target protein 
was eluted with this strategy (lane 7). Hence, we considered that it might be 
better to revert to the usual 30 mM imidazole and 500 mM NaCI wash but 















Figure 3.4. Purification of his-tagged PjHGXPRT using higher concentrations of imidazole 
(60 mM) and NaCl (1 M) in the column wash buffer. 1, Molecular weight markers (kDa); 
2, Supernatant before filtration; 3, Supernatant after filtration; 4, Crude pellet after induction; 5, 
Flow-through; 6, 5 mM imidazole wash fraction (5 ml); 7,60 mM imidazole wash fraction (5 ml) ; 
8, 1 M imidazole fraction (2ml); 9, I M imidazole fraction (2 ml). 
Figure 3.5 shows the results of such an experiment and a very pure preparation of 
PjHGXPRT was achieved (lane 8 and 9, and these two pooled fractions, lane 10). 
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Figure 3.5. Purification of his-tagged PjHGXPRT using nickel-affinity chromatography and 
larger wash volume. I L culture. 1, Molecular weight markers (kDa); 2, Supernatant before 
filtration; 3, Supernatant after filtration; 4, Crude pellet after induction; 5, Flow-through; 6, 5 mM 
imidazole wash (10 ml); 7,30 mM imidazole wash (10 ml); 8, I M imidazole (2ml); 9, further I 











3.1.3 Activation of his-tagged PjHGXPRT 
Previous work had found that PjHGXPRT, expressed with a his-tag, was inactive 
as isolated, but could be activated by incubation with partial substrates (i.e. 
hypoxanthine + PRPP without Mi+ or MgPRPP alone, conditions which do not 
result in enzyme turnover) (Phehane, 2002). However we had difficulty in 
reproducing this and found no measurable activity after several purification 
experiments. In an effort to obtain active enzyme, and thinking that the high 
imidazole and salt concentrations may be detrimental, the protein was first 
dialysed against 25 mM Tris-CI, pH 8.0, I mM OTT and I mM PMSF. 
Unfortunately, the protein precipitated after a -16 h dialysis. We then tried to 
change the medium faster by using two PO-10 desalting columns immediately 
after purification. For thi s experiment we used the preparation shown in figure 
3.5, and the final 4 ml was divided into two portions of2 ml, and each made up to 
2.5 ml (required for optimal PO-10 usage). The PO-10 columns were equilibrated 
with 25 mM Tris-Cl, pH 8.0, 1 mM OTT and 1 mM PMSF. The flow-throughs 
were collected and the protein of interest eluted in the same buffer (figure 3.6). 






Figure 3.6. Changing buffer medium using PD-IO columns (containing Sephadex™ G-25 
resin). 1, Molecular weight markers (kDa); 2, Flow-through (column I); 3, Flow-through (column 



























Figure 3.7. Induction of non his-tagged PjHGXPRT. Two cultures oftransfonned E. coli were 
grown at 37°C overnight and then aliquots were taken before (lanes I and 3) and after (lanes 2 and 
4) induction with 0.4 mM IPTG and the samples analysed by SDS-PAGE. The right hand arrow 
indicates the position of PjHGXPRT. 
The cells were pelleted, resuspended to 100 ml and lysed. The lysate was then 
subjected to centrifugation of 21 000 rpm for 20 min, and the pellet resuspended 
to the same volume as the supernatant. The composition of the supernatant and 
pellet is shown in figure 3.8 (lanes 2 and 3). Most of the protein of interest 
appeared in the pellet. The supernatant was processed further according to a 
purification protocol developed in our laboratory (Mbewe et ai, 2007), which 
consisted oftandem columns of anion exchange resin and Reactive Red-120. 
Under the conditions used, PjHGXPRT does not bind to the anion exchange resin, 
but most of the contaminating proteins do, and binds to the Reactive Red-120 
resin. The material coming straight through both columns is shown in lane 4, and 
very little protein is evident. A wash of the Reactive Red-120 column alone is 
shown in lane 5, and a small amount PjHGXPRT appears. 
The majority of PjHGXPRT was eluted with sodium pyrophosphate buffer as 
shown in figure 3.9. A number of contaminating proteins are evident, with some 
eluting earlier and others later, but it was difficult to select specific fractions with 











was dialysed against 10 mM MOPS, pH 7.0, 1 mM OTT and 1 mM PMSF, to 
provide ~ 10 ml of 1.3 mg PjHGXPRT/ml (yield 13 mg protein). 
2 3 4 5 
37 ----+ 
25 ----+ 
Figure 3.8. Purification of PjHGXPRT using DE-52 anion-exchange and Reactive Red-120 
affinity chromatography. 1, Molecular weight markers (kDa); 2, Crude supernatant after 
induction (volume 100 ml) ; 3, Crude pellet after induction (resuspended to the same volume as the 
supernatant); 4, Reactive red-120 flow-through (100 mJ); 5, Reactive red-120 wash (5 mJ, 200 mM 
NaCI, 50 roM Tris-CI, pH 8.00) after separating the two columns. The right hand arrow indicates 
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Figure 3.9. Purification of PjHGXPRT continued: Reactive Red-l20 elution profLIe. 
1, Molecular weight markers (kDa); 2-10, Fractions \-9 (I ml each, 50 mM NaPPi, 50 mM Tris-
CI, pH 8.9, I roM DTT, 1 mM PMSF). The arrow on the right indicates the position of the target 











It was disappointing to see the amount of PjHGXPRT in the crude pellet fraction 
(figure 3.8), most probably in inclusion bodies and, consequently, induction of 
protein expression was attempted at 25°C (figure 3.10). The result appeared much 
better with more PjHGXPRT appearing in the supernatant fraction (compare lanes 
2 and 3 in figures 3.8 and 3.10). The elution profile from Reactive Red-120 is 
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Figure 3.10. Purification of PjHGXPRT after induction at 25°C using DE-52 anion-exchange 
and Reactive Red·120 affinity chromatography. 1, Molecular weight markers (kOa); 2, Crude 
supernatant after induction; 3, Crude pellet after induction; 4, Flow-through from both columns; 
5, Reactive red-120 wash (5ml, 200 ruM NaC!, 50 ruM Tris·CJ, pH 8.0). The arrow on the right 
indicates the position of PjHGXPRT (-26 kOa). Equal volume aliquots were analysed by SOS-
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Figure 3.11. Purification of PjHGXPRT continued: Reactive-Red 120 elution profile. 
1, Molecular weight markers (kOa); 2-10, Fractions 1-9 (\ ml each, 50 ruM NaPPi, 50 ruM Tris-











The 9 fractions from the Reactive Red-120 column were pooled and dialysed 
against 10 mM MOPS, pH 7.0, 1 mM DTT and 1 mM PMSF. The final yield of 
PjHGXPRT was higher, ~ 10 ml of 1.6 mg protein/ml (total 16 mg), though a 
considerable amount of the enzyme was still lost in the crude pellet fraction. 
The dialysate was then concentrated using an Amicon® ultrafiltration cell and the 
resulting preparation analysed by SDS-PAGE (figure 3.12). The protein 
concentration was 22.96 mg/m!. The concentrated protein was stored in 10 ).11 






Figure 3.12. Effect or concentrating PjHGXPRT using an Amicon® ultrafiltration cell 
1, Molecular weight markers (kDa); 2, PjHGXPRT before concentrating; 3, PjHGXPRT after 
concentrating. 
3.2.2 Activation of PjHGXPRT expressed without a his-tag 
The protein as isolated was inactive but has previously found to be capable of 
being made active by incubation with partial substrates. It was also found that it 
was essential to dialyse the non his-tagged protein overnight after Reactive Red-
120 chromatography to remove the sodium pyrophosphate (Mbewe, 2005). 
Following these procedures produced protein that exhibited activities of up to 2 
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3.13. Calibration of TosoHaas G3000SW filtration HPLC column: 
Profiles of standards at different NaCI concentrations. A mixture of standards was 
onto the column at time zero in 10 mM 7.0, contaUlung20 100 
or 400 mM NaCl. The flow rate was 1 ml!min. Peaks: 1: Dextran Blue 
(2 x 3: Bovine serum albumin 000 
4: Ovalbumin 000 5: Carbonic "ntlV(l'rl'l 000 6: c (11 700 
7: 
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Figure 3.14 Calibration curves for Tosohaas TSKgel G3000SW gel mtration HPLC column. 
Standard proteins (see Table 2.1) were injected onto the column in 10 mM MOPS'TMAH, pH 7.0, 
containing either 100 mM (left panel) or 400 mM NaCI (right panel). 
3.3.2 NaCl, CaCh, and MgCh concentration dependence of the quarternary 
structure of PjHGXPRT 
The N aCI concentration dependence was detennined by injecting aliquots of 
isolated PjHGXPRT onto the column that had been equilibrated in 10 mM 
MOPS·TMAH, pH 7.0, containing 20, 50, 100 or 400 mM salt. The elution 
profiles are shown in figure 3.15. At each of the salt concentrations four peaks are 
evident. The first two are labelled A and B, and both are the enzyme of interest as 
proven by collecting the peaks and analysis by SDS-PAGE (not shown), whereas 
the two peaks eluting later were not PjHGXPRT, and represent low molecular 
weight contaminants. The proportion of A and B is clearly salt concentration 
dependent, with a greater amount of the earlier eluting material (apparently higher 
molecular weight) at low salt and almost entirely the retarded (smaller) fonn at 
high salt (the concentration of NaCI for half maximal effect is approximately 
50 mM). They are ascribed to different oligomeric fonns of PjHGXPRT, and the 
salt dependence of the equilibrium is compatible with known KCI concentration 
dependence (tetramerHdimer equilibrium) described by Keough et al (1999), 
determined by sedimentation centrifugation measurements. According to the 
standard calibration curves at 100 mM N aCI and 400 mM N aCI (figure 3.14), we 











55 kDa at 100 and 400 mM NaCI for the tetramer and dimmer, respectively. At 
low salt (20 mM) the separation of standard proteins was incomplete and as the 
column manufacturers recommend a working concentration of300 mM NaCl, we 
thought that 400 mM N aCl was more representative of an optimal separation 
profile. Also, the molecular weights obtained for the tetramer (85 kDa) and dimer 
(55 kDa) closer to the expected values for the two species. 
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Figure 3.15. HPLC gel filtration elution profiles of PjHGXPRT: NaCl dependence. Aliquots 
of protein (301l1, 1.3 mglml protein) were injected onto a TosoHaas TSKgel G3000SW column at 
time zero with running buffer of 10 mM MOPSTMAH, pH 7.0, and the concentrations of NaCl 
shown. A and B identify two putative quarternary forms of PjHGXPRT. 
The elution profiles obtained for analysis of the CaClz concentration dependence 













equilibriwn towards B - the apparently lower molecular weight form - with a half 
maximal effect at approximately 1 mM. 
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Figure 3.16. HPLC gel mtration elution profiles of PjHGXPRT: CaCh concentration 
dependence. Aliquots of isolated protein (30 fll, 1_3 mg/ml) were injected onto a TosoHaas 
TSKgel G3000SW column at time zero in 10 mM MOPS-TMAH, pH 7_0, containing the 
concentrations ofCaCI2 shown. A and B identify two putative quarternary forms of PjHGXPRT_ 
58 










The MgCh concentration dependence was determined similarly and is shown in 
figure 3.17, and is almost identical to that found for CaCho 
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Figure 3.17. HPLC gel filtration elution profiles of PjHGXPRT: MgCI2 concentration 
dependence. Aliquots of isolated protein (30 ~l, 1.3 mg/ml) were injected onto a TosoHaas 
TSKgel G3000SW column at time zero in lO mM MOPSTMAH, pH 7.0, containg the 













3.3.3 Preincubation of PjHGXPRT in 1 M NaCl 
The above suggest that incubation at high salt converts PjHGXPRT into the later 
eluting (smaller) fonn. The effect of preincubation of PjHGXPRT in 1 M NaCI 
was detennined by incubating the protein at room temperature for either 1 or 20 
min, and aliquots of the protein then injected onto the column in rurming buffer 
containing low salt (20 mM NaCI), and the results are shown in figure 3.18 (note 
difference in y-scale). It is evident that preincubation at high salt concentration 
had very little effect on the elution profile, which must mean that the rate of 
interconversion of the two fonns in the equilibrium is very rapid. 
Figure 3.1S. HPLC gel nitration elution pronles of PfHGXPRT: Effect of preincubation in 1 
M NaC!. Aliquots of isolated protein (30 fl.1, 1.3 mg/ml, preincubated at room temperature for the 
times indicated) were injected onto a TosoHaas TSKgel G3000SW column at time zero in 10 mM 
MOPS'TMAH, pH 7.0, containing 20 mM NaCI. A identifies the putative higher molecular weight 
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Figure 3.19. HPLC gel filtration elution profIles of PjHGXPRT: Effect of protein dilution. 
Aliquots of protein (3 or 6 [l.1, 1.3 or 0.13 mg/ml, i_e_ undiluted or diluted with running buffer) 
were injected onto a TosoHaas TSKgel G3000SW colwnn at time zero with running buffer of 10 
mM MOPS-TMAH, pH 7.0, containing either 20 or 50 mM NaCI as indicated_ A identifies the 
putative higher molecular weight quarternary fonn of PjHGXPRT and B marks either the smaller 
fonn or the position where it is expected to elute. 
3.3.5 NaCI concentration dependence of activated PjHGXPRT 
For analysis of the effect of activation of the protein on its oligomerisation, 
PjHGXPRT was activated by overnight incubation with 60 /!M hypoxanthine and 
1 mM PRPP at O°C. Aliquots of the activated enzyme were then injected onto the 
column in running buffer containing 20, 100 or 400 mM NaCI. Elution profiles 
are shown in figure 3.20. Essentially no difference was found between isolated 















Figure 3.20. HPLC gel filtration elution profLIes of activated PjHGXPRT: NaCI 
concentration dependence. Aliquots of protein (30 ~I, 1.3 mg/ml, activated by overnight 
incubation at O°C with 60 IlM hypoxanthine and I mM PRPP) were injected onto a TosoHaas 
TSKgel G3000SW colunm at time zero with running buffer of 10 mM MOPS-TMAH, pH 7.0, 
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Figure 3.21. [y-32PITNP-8N3-ATP concentration dependence of photolabelling of Ca2+_ 
ATPase in SR vesicles. A: Autoradiographs foUowing SDS-PAGE. Photolabelling was 
performed in 25 roM EPPS'TMAH, pH 8.5, 2 mM EDT A, 20% (v/v) glycerol, 0.002 mglml SR 
and the concentrations of [y_J2p]TNP-8Nr ATP indicated here: 1,0.001 11M; 2, 0.003 flM; 3, 0.01 
flM; 4, 0.Q3 11M; 5, 0.1 IlM; 6, 0.3 IlM; 7, 111M; 8, 3 IlM; 9,6 IlM; 10, 10 flM. 
B: Quantification. The [y}2p]TNP-8Nr ATP concentration dependence data were fitted using Eq. 
2.1, without a linear component. The data point at 10 IlM was not included in the fit. Maximum 
labelling = 0.04 moUmol; KoS(TNP) = 0.16 11M. 
The concentration dependence of ATP inhibition at 0.3 ~ [y_32p]TNP-8N3-ATP 
showed that complete inhibition is achieved in the millimolar range, and a fit of 
the data produced Ko.5(ATP) = 57 J1M. The true Kt(ATP) was derived using eq. 2.3 
(Methods section) and produced 20 JlM, which is almost identical to that obtained 
previously with wild type rabbit Ca2+-ATPase produced in COS-l cells under the 
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Figure 3.22. ATP inhibition of photolabelling of Ca2+-ATPase in SR vesicles. A: 
Autoradiographs following SDS-PAGE. Photo labelling was performed in 25 mM EPPS·TMAH, 
pH 8.5, containing 2 mM EDT A, 20% v/v glycerol, 0.002mglml SR, 0.3 flM [y_32p]TNP-8N3-
ATP, and the concentrations of ATP indicated here: 1, 0 flM; 2, 0.3 flM;3, 1 11M ;4,3 flM ;5, 10 
11M; 6,30 flM ; 7, 100 flM; 8,300 flM; 9,1000 11M; 10,3000 flM. B: Quantification. ATP 
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Figure 3.23. Autoradiographs of the pH dependence of photolabelling of isolated (left panel) 
and active (right panel) PjHGXPRT with [y-3lPITNP-8N3-ATP at pH 6.0 (25 mM 
MES'TMAH), 7.0 (25 mM MOPS'TMAH), and 8.0 (EPPS'TMAH) and effect of 4'-iodo-
chalcone. A: In addition to the buffers, the photolabelling medium contained 2 mM EDTA, 20% 
v/v glycerol, 0.0 I mg/ml PjHGXPRT, and either 0.3, 1.0,3.0, and 30 j.l.M [y_32p]TNP-8Nr ATP. In 
the case of the 5th lane at each pH the nucleotide concentration was 3 j.l.M with I OIlM chalcone. In 
Band C, I mM MgCl2 or CaCl2 replaced the EDT A, respectively. 
The effect of including 1 0 ~ 4' -iodo-chalcone on the photolabelling at 3 J.lM 
[y-32p]TNP-8N3-ATP is also shown for each of the conditions, and in general, the 
chalcone had no effect or enhanced labelling. The one exception was with 
isolated enzyme in EDT A at pH 6.0 where the labelling was less. Overall it 
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Figure 3.24. Concentration depeudence of photolabeJling of PfHGXPRT with [y_32P1TNP_ 
8N 3-ATP at pH 6.0 and effect of PRPP. A: Autoradiographs after SDS-PAGE. PhoiolabeJling 
ofisolated (left) and active (right) PjHGXPRT was perfonned in 25 ruM MES'TMAH, pH 6.0, 
containing 2 mM EOTA, 20% v/v glycerol, 0.01 mglml PjHGXPRT, and 0.01 to 30 I'M of the 
photolabel as indicated here: 1, 0.0 I I'M; 2, 0.03 I'M; 3, O.II1M; 4. 0.3 I'M; 5,1 I'M; 6, 3 I'M; 7, 6 
I'M; 8, 10 I'M; 9, 20 I'M; 10, 30I'M; II, EMPTY; 12,3 I'M + I roM PRPP. B: Quantification. 
Concentration data were fitted using Eq. 3.1 (with linear component for isolated PjHGXPRT) to 
yield the K".5ITNP.8NJ.ATP) = 1.24 and 12.24 I'M with isolated and active PjHGXPRT respectively 
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Figure 3.25. Concentration dependence of photolabelling of PjHGXPRT with [y_32 PlTNP_ 
8Nr ATP at pH 8'.0 and effect of PRPP. A: Autoradiographs after SDS-PAGE. PhotolabeJling 
of isolated (left) and active (right) PjHGXPRT was performed in 25 mM EPPSTMAH, pH 8.0, 
containing 2 mM EDT A, 20% v/v glycerol, 0.0 I mg/ml PjHGXPRT, and 0.01 to 30 J..LM of the 
photolabel as indicated here: 1,0.01 !-1M; 2,0.03 ).1M; 3, O.l)lM; 4, OJ )lM; 5,1 f!M; 6, 3 J..LM; 7, 6 
J..LM; 8, 10 )lM; 9, 20 J-lM; 10, 30j.lM; 11, EMPTY; 12,3 )lM + I mM PRPP. B: Quantification. 
Concentration data were fined using Eq. 3.1 (with linear component for isolated PjHGXPRT) to 
yield the Ko.SCfNP-8NJ-ATPI = 1.12 and 6.05 11M with isolated and active PjHGXPRT respectively and 
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3.26. ITC data for titration of EDT A with a model exothermic reaction. 
0.5 in 10mM 
The fIrst 
5.6 
was 0.5 III and the 
was titrated with 5 mM in the same 
ones 2 The heats 
(llcaJJs) for each IDliectllon and concentrations of EDT A and were used to calculate the 
kcaJJmole of mH~c"am and molar and from a fit of the data to 3.3 for a one 
site vUJ ..... u.,'" model. The parameters obtained were: 3.42 X 105 +/- 2.80 x 104 
in ,",ULU'''jJ) = -4316 +/- 26.53 caJJmole and 
in entropy 10.8 were calculated. Prior to heats of dilution were 












in the region of I %. For this reason, two titrations of t % and 0.2% DMSO into 
water were performed and shown in figure 3.27, trace A and B respectively. At 
the higher concentration there was a slight decrease in amount of heat produced 
on each injection over the titration period due most probably to the volume of the 
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Figure 3.27. Heat effects on dilution of DMSO jo water. A: ] % DMSO (in water) injected into 
degassed distilled water in the cell. B: 0.2% DMSO. An initial aJiquot of 0.5 ~I DMSO was 
injected, followed by 17 injections of 2 ~l each. 
In an effort to keep the chalcone in solution and to try to minimize the 
concentration of DMSO, the solubility of the chalcone in DMSO was investigated 
at pH 7.0, 8.0, and 9.0 at room temperature and the results obtained are shown in 
table 3.1. It is evident that the solubility increases at higher pH and that the 
highest concentration at which the chalcone is soluble at the intennediate pH of 8 












Table 3.1. of 4'-iodo-cbalcone at and 9.0. The chalcone at the 
concentrations shown was incubated in 10% DMSO and 100 mM in either 20 mM 
7.0,20 mM 9.0. The samples 






"'HU ..... V.,,,,, is a .... ,..,f""'~,1- UUUVH,V 










4.0 -',--------------- --.------------------, 
3.8 
Chalcone Ulto buffer 
3.6 
U 





0 3.4 ::::1. 
Buffer into PjHGXPRT 
3.2 Bu ffer i nln lou ffer 
3.0~------~--------,_-------,-----_.--------~----~ 
o 20 40 
Time (min) 
Figure 3.28. Titration of P.fJJGXPRT wit 11 4 '-iodo-chalcone. Binding was srudied with 6.0 liM 
(0 .15 mg/ml) PjHGXPRT (in the cell) and 250 IJ.M chalcone (syringe) and 10 roM EPPSTMAH, 
pH 8.2, I mM CaCl2 and 10% DMSO in both compartments. Controls were: chalcone into buffer, 
buffer into PjHGXPRT, and buffer into buffer as indicated. The chalcone was added to DMSO 
before any of the other constituents as the cbalcone precipitates otherwise. 
In the next experiment the protein concentration was increased 3-fold and 6-fold, 
the enzyme activated by prior incubation with 60 j.l.M hypoxanthine and 1 mM 
PRPP, and the eaCh omitted. This necessitated the inclusion of the substrates in 
the cell and syringe. The results are shown in figure 3.29. Active enzyme at a 3-
fold higher concentration (blue trace) gave the same results as before. At 32 ~ 
PjHGXPRT, the heat produced at each injection was higher and there was some 
semblance of a curved titration effect over the titration period. However, the 
amoW1t of heat produced that could perhaps be attributable to binding was smaller 
than the nonspecific component remaining at the end of the titration, which may 












the DMSO effect seemed unpredictable and sometimes too large for the small 
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Figure 3.29. Titration of PjHGXPRT with 4' -iodo-chalcone: effect of increasing the amount 
of protein, using activated enzyme, and removing CaCI2• Binding was studied with either 16 
(blue trace) or 32 (red trace) ~M PjHGXPRT (in the cell) and 250 ).lM chalcone (syringe) and 10 
(with the lower protein concentration) or 50 (higher protein) rnM EPPSTMAH, pH 8.2, 10% 
DMSO, 60 ).lM hypoxanthine and I mM PRPP in both compartments. The concenlTation of buffer 
coming in with the protein was also compensated for in the syringe compartment by adding 3.2 
and 6.5 mM: MOPSTMAH, pH 7.0 a1 16 and 32 IJM protein, respectively. The control was 
chalcone into buffer (black trace). The chalcone was added to DMSO before any of the other 
constiruents as the chalcone precipitates otherwise. 
We experimented with trying to obtain soluble chalcone in lower concentrations 
of OM SO, and found that if the stock, concentrated chalcone in neat OMSO was 












chalcone went into solution. This meant that the concentration of DMSO in the 
syringe could be 0.1 %, instead of the previous 10%. 
Accordingly, we devised such an experiment using a new preparation, using the 
protein as isolated as we1l as activated (yielding a specific activity of2.86 ,umoles 
GMP/minlmg of protein) and the results are shown in figure 3.30. Here no 
DMSO was included in the cell compartment and 0.1 % was in the syringe due to 
diluting the chalcone. Clearly, no heat attributable to chalcone binding can be 
discerned and the heats of titration are what is expected for diluting 0.1 % DMSO 
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Figure 3.30. Titration of PjHGXPRT with 4' -iodo-chalcone; diminishing the DMSO effect. 
In these experiments the chalcone was dissolved in buffer by diluting the stock concentrated neat 
DMSO solution lOOO-fold and heating at 35°C for a few minutes. In the first titration (black 
trace), isolated PjHGXPRT (0.92 mglml, 36 llM) was titrated with chalcone (l00 ).lM) and both 
compartments contained 50 mM EPPS·TMAH, pH 8.2 and 0.39 mtv! MOPSTMAH, pH 7.0 (the 
latter because the buffer in which the stock protein was dissolved). In the second titration (red 
trace), conditions were identical with I mM CaCh being added to both compartments. In the third 
titration (blue trace), the PjHGXPRT was activated by prior incubation with both substrates (I mM 
hypoxanthine, 2 ruM PRPP) and MgCl2 (0.1 mM). Both compartments contained 50 mM 
EPPS'TMAH, pH 8.35, 0.39 mM MOPS'TMAH, pH 7.0, 1 mM hypoxanthine, 2 mM PRPP and 
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inosine, or xanthine monophosphate). However, examination of the apo structures 
of human (figure 4.1) and Toxoplasma gondii (figure 1.7F) reveals that the active 
site is wide open with the flexible catalytic loops pulled back. There is in fact 
plenty of room for a large probe to be accommodated. 
Active site 
/ 
Figure 4.1 Human HGPRT apoenzyme. A semitransparent surface representation of the 
unliganded fonn of the enzyme indicating the open active site. 
Even the polyphosphate tail may be tolerated by extending out into the medium. 
An attempt to dock TNP-8N3-ATP into the active site of the human apoprotein 
with the phosphates extending from the active site is shown in figure 4.2. The 











Figure 4.2. Docking ofTNPATP into the active site of PjHGXPRT. 
Preliminary experiments on the pH dependence of photolabelling of isolated and 
active PjHGXPRT with [y}2PjTNP-8N3-ATP suggested that derivitisation may be 
more efficient in EDT A, compared to labelling in the presence of the divalent 
cations (Mi+ and Ca2). 4' -iodo-chalcone appeared to have little effect on 
derivatisation, compatible with it binding to an allosteric site (if indeed the probe 
was derivatising the active site, see below). An allosteric site is suggested from 
the fact that the chalcone inh bits activity in a non competitive manner with 
respect to PRPP (Mbewe and McIntosh, unpublished results). 
More detailed investigation of derivatisation at pH 6.0 and 8.0 in EDT A (in the 
absence of the divalent cations) suggested that binding is 5-10 fold tighter for the 
isolated PjHGXPRT compared with the active enzyme. However, the presence of 
a relatively large apparently non-specific component with the isolated protein 
makes the conclusion somewhat uncertain and repeat experiments need to be 
done. 
An important aspect of the results is that the extent of derivatisation varies from 
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Figure 4.3. PfHGXPRT active site. This diagram illustrates the interactions of immucillinHP 
(light blue). pyrophosphate (pink), and the two Mg2+ (green spheres) in the active site of the 
transition state mimic. Note how pyrophosphate interacts strongly with the two Mg2+. and the fact 
that there is only one interaction of the divalent cations with the protein itself (Asp204). 
(Structure determined by Shi et ai, \999a). 
Isothermal titration calorimetry 
ITC is a powerful technique for analysis of binding reactions and provides a 
profile of useful thermodynamic parameters. We sought to characterise the 
interaction of 4' -iodo-chalcone with PjHGXPRT. 
Initially, we performed a model binding experiment, suggested by the 
manufacturer, in which EDT A was titrated with CaCh, and the results indicated 
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